ORIGINAL RESEARCH
Published on 12 Aug 2022
Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
![Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway](https://www.frontiersin.org/files/myhome article library/906043/906043_Thumb_400.jpg)
doi 10.3389/fphar.2022.906043
- 2,061 views
- 4 citations
6,187
Total downloads
17k
Total views and downloads
You will be redirected to our submission process.
ORIGINAL RESEARCH
Published on 12 Aug 2022
ORIGINAL RESEARCH
Published on 25 Apr 2022
SYSTEMATIC REVIEW
Published on 17 Mar 2022
ORIGINAL RESEARCH
Published on 03 Feb 2022
REVIEW
Published on 25 Jan 2022